| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/08/1999 | CA2302025A1 Tricyclic 3-oxo-propanenitrile compounds |
| 04/08/1999 | CA2298854A1 Compositions and methods for identifying pkb kinase inhibitors |
| 04/07/1999 | EP0906959A2 Aminopeptidase from Staphylococcus aureus |
| 04/07/1999 | EP0906956A2 MurD from Streptococcus pneumoniae |
| 04/07/1999 | EP0906912A1 Indanol derivatives, process for their preparation and pharmaceutical compositions containing them |
| 04/07/1999 | EP0906910A1 Chromene derivatives and salts thereof, and pharmaceuticals containing the same |
| 04/07/1999 | EP0906752A1 Use of a plant extract of the Rosaceae family |
| 04/07/1999 | EP0906724A1 Pseudoplastic film-forming acidic chlorite composition as teat dip |
| 04/07/1999 | EP0906433A1 Protein tyrosine phosphatases of hematopoietic cells |
| 04/07/1999 | EP0906426A1 Antibodies to the ed-b domain of fibronectin, their construction and uses |
| 04/07/1999 | EP0906421A1 Enhanced efficacy of liposomal antisense delivery |
| 04/07/1999 | EP0906416A1 Molecules comprising an impdh-like binding pocket and encoded data storage medium capable of graphically displaying them |
| 04/07/1999 | EP0906315A1 Spiro-piperidine derivatives and their use as therapeutic agents |
| 04/07/1999 | EP0906310A1 OXADIAZOLE BENZENESULFONAMIDES AS SELECTIVE $g(b) 3? AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY |
| 04/07/1999 | EP0906309A1 Modified form of the r(-)-n-(4,4-di(3-methylthien-2-yl)but-3-enyl)-nipecotic acid hydrochloride |
| 04/07/1999 | EP0906307A1 Substituted imidazoles having cytokine inhibitory activity |
| 04/07/1999 | EP0906286A1 5-aminopyrazoles useful as selective inhibitors of the protein tyrosine kinase p56ick |
| 04/07/1999 | EP0906284A1 Tricyclic amine derivatives |
| 04/07/1999 | EP0906282A1 Heterocyclylmethylamino derivatives of cyclobutene-3,4-diones as potassium channel modulators |
| 04/07/1999 | EP0906279A1 Novel pyrrole derivatives |
| 04/07/1999 | EP0906276A1 Novel vitamin d analogues |
| 04/07/1999 | EP0906273A1 Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers |
| 04/07/1999 | EP0906268A1 Alkyloxyamino substituted fluorenones and their use as protein kinase c inhibitors |
| 04/07/1999 | EP0906119A1 Method of treatment |
| 04/07/1999 | EP0906112A2 Use of alkylaryl polyether alcohol polymers for the treatment of chronic pulmonary inflammation |
| 04/07/1999 | EP0906110A1 Dna vaccine formulations |
| 04/07/1999 | EP0906108A1 Method of treating heart failure with endothelin antagonists |
| 04/07/1999 | EP0906103A1 Vitronectin receptor antagonists |
| 04/07/1999 | EP0906102A1 A process for regulating vagal tone |
| 04/07/1999 | EP0906100A1 Use of 5-ht 1a? receptor antagonists for the treatment of urinary incontinence |
| 04/07/1999 | EP0906098A1 Virginiamycin mixture |
| 04/07/1999 | EP0906096A1 Agent for inhibiting leukocyte invasion of tissues |
| 04/07/1999 | EP0906091A1 Amidinohydrazones as protease inhibitors |
| 04/07/1999 | EP0906088A1 Liposomal antineoplaston therapies with markedly improved antineoplastic activity |
| 04/07/1999 | EP0770059B1 Substituted benzamidines, their production and their use as medicaments |
| 04/07/1999 | EP0752884A4 Method of treating auto-immune diseases using type one interferons |
| 04/07/1999 | EP0697882A4 Use of glutathione diesters |
| 04/07/1999 | EP0632033B1 Novel benzopyran derivative |
| 04/07/1999 | EP0600868B1 Recombinantly produced lipases for therapeutical treatment |
| 04/07/1999 | EP0481994B1 Metallo-organic cobalt compounds and uses thereof |
| 04/07/1999 | CN1213372A Heterocycle-condensed morphinoid derivatives (II) |
| 04/07/1999 | CN1213370A Substituted sulfonic acid N-[(aminoiminomethyl) phenylalkyl]-azaheterocyclamide compounds |
| 04/07/1999 | CN1213369A Quinoxalinediones |
| 04/07/1999 | CN1213368A Hydroxamic acid based collagenase inhibitors |
| 04/07/1999 | CN1213313A Use of thexpahyrin in preparation of medicament for use with a chemotherapeutic agent in cancer chemosensitization |
| 04/07/1999 | CN1213307A Novel substituted imidazolium compounds |
| 04/07/1999 | CN1213306A Novel substituted imidazolium compounds |
| 04/07/1999 | CN1213305A Novel cycloalkyl substituted imidazolium compounds |
| 04/07/1999 | CN1213304A Use of 4-phenyl-3,6-dihydro-2H-pyridyl derivatives ad NMDA receptor subtype blockers |
| 04/07/1999 | CN1212878A Moxibustion liquid --moxibustion fixing paste and its preparation method and use method |
| 04/07/1999 | CN1212869A Fixed-dose association of angiotensin-converting enzyme inhibitor and of calcium channel antagonist, method for preparation and use thereof in treatment of cardivas cular illnesses |
| 04/07/1999 | CN1042795C Antioxidant neuroprotective use of and method of treatment using hydroxycarbazole compounds |
| 04/06/1999 | US5892113 Protease inhibitors |
| 04/06/1999 | US5892099 Autoimmune disease, bone disorders, liver damage, cardiovascular disorders |
| 04/06/1999 | US5892069 Estrogenic compounds as anti-mitotic agents |
| 04/06/1999 | US5892045 4-aryl-3-hydroxyquinolin-2-one derivatives as ion channel modulators |
| 04/06/1999 | US5892039 Piperazino derivatives as neurokinin antagonists |
| 04/06/1999 | US5892012 Rab Proteins |
| 04/06/1999 | US5892000 From hybridomas 2g6 and b14; for immunoassay test kit used in diagnosis of athlerosclerosis and diabetes |
| 04/06/1999 | US5891909 Amidinohydrazones as protease inhibitors |
| 04/06/1999 | US5891894 2-amino oxazole derivatives; antagonists of platelet activating factor useful in treatment of asthma, inflammation, cardiovascular disorders, renal diseases, or as contraceptives |
| 04/06/1999 | US5891893 5-amino-1,2,4-oxa(or thia)diazoles; antagonists of platelet activating factor useful in treatment of asthma, allergies, inflammation, cardiovascular diseases, renal diseases, or as contraceptives |
| 04/06/1999 | US5891878 Enzyme inhibitors of phosphodiesterase or tumor necrosis factor |
| 04/06/1999 | US5891873 Particularly alzheimer's disease. examples include aminoguanidines and amphotericin b. |
| 04/06/1999 | US5891863 Prevent resorption of prosthetic bone |
| 04/06/1999 | US5891856 Nonmutating cells by treatment with metabolites and aminoalkylphosphorothioate |
| 04/06/1999 | US5891852 Serine protease inhibitors-cycloheptane derivatives |
| 04/06/1999 | US5891680 Dna molecule encoding an active il-12 fusion protein with at least two polypeptide monomers linked by heterologous polypeptide linker; stimulates ifn-alpha production, enhances antitumor immunity and cell mediated immunity |
| 04/06/1999 | US5891678 Isolated polynucleotide encoding bacterial enzyme involved in mediating protein secretion; treatment of invasive infections and toxigenic diseases; antibiotic screening and development |
| 04/06/1999 | US5891672 Polynucleotides encoding GTP cyclohydrolase II (ribA) |
| 04/06/1999 | US5891655 Screening low molecular weight compounds for modulation of fibroblast growth factor activity such as mitogenesis of receptor expressing cells as well as competitive binding with heparin to receptor and dimerization |
| 04/06/1999 | US5891477 Non-steroidal anti-inflammatory agents inhibition of fibrotic response to an implanted device |
| 04/06/1999 | US5891472 Topical treatment for administering nitric oxide in lipid based carriers |
| 04/06/1999 | US5891435 Antidiabetic agents and antigens |
| 04/06/1999 | CA2152794C Diarylalkyl piperidines useful as multi-drug resistant tumor agents |
| 04/06/1999 | CA2135070C Use of guanylate cyclase inhibitors in the treatment of shock |
| 04/06/1999 | CA2000804C Quinolyloxazole-2-ones useful as proteinkinase c inhibitors |
| 04/06/1999 | CA1340485C Peptide analogs and their use as haptens to elicit catalytic antibodies |
| 04/01/1999 | WO1999015894A2 Method of identification of leads or active compounds |
| 04/01/1999 | WO1999015703A1 Inhibition of an fgf-binding protein using ribozymes |
| 04/01/1999 | WO1999015654A2 Tie receptor tyrosine kinase ligand homologues |
| 04/01/1999 | WO1999015653A2 Tie ligand homologues |
| 04/01/1999 | WO1999015648A1 Antisense oligonucleotides against thymidylate synthase |
| 04/01/1999 | WO1999015635A1 Human ste20-like stress activated serine/threonine kinase |
| 04/01/1999 | WO1999015530A1 Tetrazole-containing rapamycin analogs with shortened half-lives |
| 04/01/1999 | WO1999015529A1 MODULES OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 04/01/1999 | WO1999015526A2 N-5,6,7,8-tetrahydro(1,6)naphthyridine-n'-phenylurea derivatives |
| 04/01/1999 | WO1999015525A1 Carboxamidothiazole derivatives, preparation, pharmaceutical compositions containing them |
| 04/01/1999 | WO1999015524A1 Thiazole derivatives |
| 04/01/1999 | WO1999015523A1 Bisethers of 1-oxa, aza and thianaphthalen-2-ones as phospholamban inhibitors |
| 04/01/1999 | WO1999015521A1 Benzothiophenes |
| 04/01/1999 | WO1999015508A1 Vitronectin receptor antagonists |
| 04/01/1999 | WO1999015507A1 Hydrazono-benzazulene derivatives, pharmaceutical compositions and intermediates |
| 04/01/1999 | WO1999015506A1 Tricyclic compounds, preparation method and said method intermediates, application as medicines and pharmaceutical compositions containing same |
| 04/01/1999 | WO1999015505A1 1,5-diphenylpyrazole derivatives |
| 04/01/1999 | WO1999015503A2 Process for making diaryl pyridines useful as cox-2 inhibitors |
| 04/01/1999 | WO1999015500A1 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 04/01/1999 | WO1999015490A1 C3a receptor ligands |
| 04/01/1999 | WO1999015200A1 MEDICINAL COMPOSITION CONTAINING gp34 BINDING INHIBITOR AS THE ACTIVE INGREDIENT |
| 04/01/1999 | WO1999015198A2 Agents for combating bacterial meningitis |